KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Agenus (AGEN) Research & Development (2016 - 2025)

Agenus (AGEN) has 16 years of Research & Development data on record, last reported at $23.6 million in Q3 2025.

  • For Q3 2025, Research & Development fell 42.53% year-over-year to $23.6 million; the TTM value through Sep 2025 reached $105.6 million, down 43.97%, while the annual FY2024 figure was $155.5 million, 33.7% down from the prior year.
  • Research & Development reached $23.6 million in Q3 2025 per AGEN's latest filing, down from $26.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $66.7 million in Q4 2023 and bottomed at $21.5 million in Q1 2025.
  • Average Research & Development over 5 years is $43.5 million, with a median of $43.9 million recorded in 2024.
  • Peak YoY movement for Research & Development: surged 50.37% in 2021, then crashed 51.0% in 2025.
  • A 5-year view of Research & Development shows it stood at $53.5 million in 2021, then fell by 0.39% to $53.3 million in 2022, then grew by 25.23% to $66.7 million in 2023, then plummeted by 49.38% to $33.8 million in 2024, then crashed by 30.14% to $23.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $23.6 million in Q3 2025, $26.7 million in Q2 2025, and $21.5 million in Q1 2025.